Koios Beverage Corp. has announced that it will be launching two additional products in October to augment its existing line of beverages.
The first product slated for release in October is a beverage infused with cannabidiol (CBD), a cannabinoid derived from hemp plants, along with Koios’ proprietary nootropic stack.
CBD is commonly used in medical practice to deal with inflammation, pain, anxiety, and epileptic seizures. Unlike THC, which is also produced in the cannabis plant, CBD is not a psychoactive cannabinoid and does not cause the sensation of ’getting high’ which is often associated with marijuana.
Nootropic supplements are used to enhance human productivity without using harmful chemicals or stimulants. Koios products can enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity.
“We are just scratching the surface of what cannabinoids like CBD can do for human health,” said Miller. “CBD is the best researched of all the cannabinoids within the cannabis plant, and is well known for its restorative effect on human health, and in dealing with various types of pain.
“With our focus on creating optimal human performance and health through our natural supplements, a CBD-infused beverage was a natural next step,” Miller added. “With our current nootropic stack we will bring a product to market that aims to produce high levels of natural focus while simultaneously creating calming effects for the end user. A CBD infused beverage will be a tremendous value to the market and will allow us to come one step closer to realizing our vision of helping a billion people live healthier lives.”
The second product slated for October will also be released through the Cannavated subsidiary, and will be a collaboration with the Company’s partner Keef Brands, a division of CanCore Concepts Inc. (CanCore).
Keef Brands will manufacture, market and sell a line of beverages that are not only infused with THC, but also contain the nootropic supplements from the Koios line of brain enhancing functional beverages. The resulting product will be the first in the world to combine cannabis infusion with nootropic supplements that enhance the consumer’s mental acuity.
Keef Brands has the exclusive rights to the Koios blend for Colorado, with the option of expanding the licensing agreement to Canada and the U.S., provided it complies with all rules and regulations in the markets where cannabis has been made legal.
The timing of the release of these products was pushed back due to the overwhelmingly positive result we have had launching our Pear Guava flavour.
“The product sold out in its first month and forced us to alter our production schedule to meet the demand of our customers and retail partners,” said Miller. “The timing on these new releases is critical and we want to ensure proper vertical alignment with our distributors as we approach the busy season.”